Stocks › CAR-T Therapy › NVS

Novartis AG NVS

US equityMarket cap rank #46CAR-T Therapy Cancer Research

$162.55 +$0.62 (+0.38%)

Market closed · Nov 6, 8:20 pm ET · Last extended-hours $162.55 0.00%

Open$159.40

Prev close$161.93

Day range$159.36 – $163.11

Volume2.00M

Market cap$307.00B

P/E (TTM)31.0

Dividend yield2.92%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership46.1%+7.81 pts vs. prior quarter

Institutions holding2,369-17 vs. prior quarter

Insider trades (recent)0 buys / 2 sellsNet selling

Short interest0.29% of floatDays to cover 3.2 · as of 15 Oct 2026

Short-sale volume share20.9%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$44.34M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 21.4% of shares outstanding.

Largest holders

BlackRock7.69%
UBS Asset Management4.88%
Vanguard Capital Management, LLC4.13%
Norges Bank Investment Management2.43%
Sandoz Family Office SA2.24%
Geode Capital Management, LLC0.95%
GQG Partners, LLC0.89%
Fisher Investments0.87%

By investor type

Mutual Fund38.44%
Private Company2.68%
Sovereign Wealth Fund2.43%
Government Pension Fund0.96%
Public Company0.82%
Hedge Fund0.35%
Insurance Company0.22%
Family Office/Trust0.12%

Reported short interest has held roughly steady near 0.29% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Invesco Capital Management LLC	Mutual Fund	2026/Q3	+959,491	0.1%
Vanguard Capital Management, LLC	Mutual Fund	2026/Q3	+760,952	4.1%
Harvest Portfolios Group Inc.	Mutual Fund	2026/Q3	+447,170	0.0%
Amundi Asset Management	Mutual Fund	2026/Q3	+395,909	0.6%
J.P. Morgan Asset Management, Inc.	Mutual Fund	2026/Q3	+362,324	0.5%
Amundi Asset Management	Mutual Fund	2026/Q3	+1,483,535	0.7%
Wellington Management Group	Mutual Fund	2026/Q3	+593,865	0.3%
Vanguard Capital Management, LLC	Mutual Fund	2026/Q3	+484,505	4.1%
Vanguard Asset Management, Limited	Mutual Fund	2026/Q3	+326,465	0.5%
UBS Asset Management	Mutual Fund	2026/Q3	+2,059,344	4.9%
Wellington Management Group	Mutual Fund	2026/Q3	+583,043	0.3%
ClearBridge Investments, LLC	Mutual Fund	2026/Q3	+451,932	0.0%
WCM Investment Management	Mutual Fund	2026/Q3	+1,917,545	0.4%
Holocene Advisors, LP	Hedge Fund	2026/Q3	+1,037,332	0.1%
Millennium Management LLC	Hedge Fund	2026/Q3	+758,029	0.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
11 Aug 2024	Robert Kowalski	Chief People & Organization Officer	Intent to Sell (Form 144)	-6,566	$111.72	–
21 May 2024	Aharon Gal	Chief Strategy & Growth Officer	Intent to Sell (Form 144)	-2,500	$101.93	–

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Oct 2026	5,585,310	0.3%	3.2
30 Sep 2026	5,624,031	0.3%	2.9
15 Sep 2026	5,195,725	0.3%	1.5
31 Aug 2026	5,625,158	0.3%	4.2
14 Aug 2026	4,993,689	0.3%	3.4
31 Jul 2026	5,240,722	0.3%	2.7

Discussion

No comments yet — be the first to weigh in on NVS.